Changes are happening - please bear with us while we update our site. Click here to give us your advice and feedback.
Get expert investment analysis on the Australian stockmarket, economy and property from Rask Media’s chosen fund managers, selected analysts and writers. Stay up to date with your preferred experts by creating a free Rask account.
No matter how experienced an investor you are, the decision of when to invest money can naturally provoke a feeling of uncertainty or apprehension.
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished down -0.46% to 7163.30.
The price-to-earnings (P/E) ratio is one of the most commonly used metrics in financial analysis as it helps investors understand and compare company valuations.
The Resmed CDI (ASX: RMD) share price is down over 30% over the past 12 months as analysts and investors weigh up the long-term impact of GLP-1 treatments on RMD’s obstructive sleep apnea (OSA) market.
Global energy markets will need to evolve dramatically over the next three decades. Worldwide, the population is forecast to grow by nearly 2 billion1 and global living standards are expected to rise as per capita consumption increases – and all this against the backdrop of a growing push towards decarbonisation.
The local share market fell for a second straight day on Tuesday, ahead of a flurry of central bank meetings, and following the release of a set of minutes from the Reserve Bank of Australia that were taken as implying that the local central bank is considered raising rates.
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished down -0.47% to 7196.60.
I outline 5 of my favourite ETFs in Australia. But be aware: these ETFs won’t be right for everyone, so keep reading (and definitely read the PDS & TMD of each fund). Watch it live – Wednesday at 12 noon.
Marcus Today does Technical Scans every day, and on 15 September 2023, they turned up four big stocks (five if you include Resmed CDI (ASX: RMD), seven including resources) that are interestingly oversold on weekly charts.
No matter how experienced an investor you are, the decision of when to invest money can naturally provoke a feeling of uncertainty or apprehension.
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished down -0.46% to 7163.30.
The price-to-earnings (P/E) ratio is one of the most commonly used metrics in financial analysis as it helps investors understand and compare company valuations.
The Resmed CDI (ASX: RMD) share price is down over 30% over the past 12 months as analysts and investors weigh up the long-term impact of GLP-1 treatments on RMD’s obstructive sleep apnea (OSA) market.
Global energy markets will need to evolve dramatically over the next three decades. Worldwide, the population is forecast to grow by nearly 2 billion1 and global living standards are expected to rise as per capita consumption increases – and all this against the backdrop of a growing push towards decarbonisation.
The local share market fell for a second straight day on Tuesday, ahead of a flurry of central bank meetings, and following the release of a set of minutes from the Reserve Bank of Australia that were taken as implying that the local central bank is considered raising rates.
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished down -0.47% to 7196.60.
I outline 5 of my favourite ETFs in Australia. But be aware: these ETFs won’t be right for everyone, so keep reading (and definitely read the PDS & TMD of each fund). Watch it live – Wednesday at 12 noon.
Marcus Today does Technical Scans every day, and on 15 September 2023, they turned up four big stocks (five if you include Resmed CDI (ASX: RMD), seven including resources) that are interestingly oversold on weekly charts.
Want to level-up your analytical skills and investing insights but don’t know where to start? We can help. Join 40,000+ Australian investors on our mailing list today and we’ll send you our favourite podcasts, courses, resources, investment articles and podcasts every week. Delivered to your inbox every Sunday morning. Grab a coffee and let Owen and the team bring you the best investment insights every week.
